Functional heterogeneity of mesenchymal stem cells from natural niches to culture conditions: implications for further clinical uses
- PMID: 32699947
- PMCID: PMC7375036
- DOI: 10.1007/s00018-020-03600-0
Functional heterogeneity of mesenchymal stem cells from natural niches to culture conditions: implications for further clinical uses
Abstract
Mesenchymal stem cells (MSC) are present in all organs and tissues. Several studies have shown the therapeutic potential effect of MSC or their derived products. However, the functional heterogeneity of MSC constitutes an important barrier for transferring these capabilities to the clinic. MSC heterogeneity depends on their origin (biological niche) or the conditions of potential donors (age, diseases or unknown factors). It is accepted that many culture conditions of the artificial niche to which they are subjected, such as O2 tension, substrate and extracellular matrix cues, inflammatory stimuli or genetic manipulations can influence their resulting phenotype. Therefore, to attain a more personalized and precise medicine, a correct selection of MSC is mandatory, based on their functional potential, as well as the need to integrate all the existing information to achieve an optimal improvement of MSC features in the artificial niche.
Keywords: Aging diseases; Conditioned medium; Diabetes; Exosomes; Extracellular vesicles; Lupus; Regenerative medicine; Secretome.
Conflict of interest statement
The authors declare the following competing interests: F.J.V and N.E are co-inventors of a patent (“Human uterine cervical stem cell population and uses thereof”) owned by GiStem Research, of which L.A.C, N.E, L.O.G, J.S, P.P J.S. and F.J.V are shareholders. The funding sponsors had no role in the design of this review, in the collection, analyses, or interpretation of data, in the writing of the manuscript, or in the decision to publish the results.
Figures
References
-
- McIntyre LA, Moher D, Fergusson DA, Sullivan KJ, Mei SH, Lalu M, Marshall J, McLeod M, Griffin G, Grimshaw J, Turgeon A, Avey MT, Rudnicki MA, Jazi M, Fishman J, Stewart DJ. Efficacy of mesenchymal stromal cell therapy for acute lung injury in preclinical animal models: a systematic review. PLoS One. 2016;1(11):e0147170. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
